Integrative Metabolomics and Systems Pharmacology Reveal PPARγ-Centered Antidiabetic Mechanisms of Caulerpa racemosa and Its Bioactive Compounds

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder requiring safe, multitarget therapeutic strategies. Marine macroalgae represent an underexplored source of bioactives with pleiotropic metabolic effects. This study investigated the antidiabetic potential of an ultrasound-assisted ethanolic extract of <i>Caulerpa racemosa</i> (UAECr) and its key phytosterol, campesterol, through an integrative framework combining metabolomics, network pharmacology, molecular docking, molecular dynamics simulation, and in vitro validation. Untargeted ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) metabolomics characterized UAECr constituents, followed by in silico bioactivity prediction, target-network analysis, molecular docking, and 100 ns molecular dynamics simulation of the peroxisome proliferator-activated receptor gamma (PPARγ)-campesterol complex. Functional validation was performed in differentiated 3T3-L1 adipocytes assessing glucose uptake, PPARγ expression, dipeptidyl peptidase 4 (DPP-4) inhibition, and cytotoxicity. Metabolomics identified campesterol as a prominent bioactive. Network pharmacology highlighted PPARγ as a central hub, supported by strong docking affinity of campesterol toward PPARγ (-11.4 kcal/mol) and DPP-4 (-8.3 kcal/mol). Molecular dynamics simulations demonstrated stable PPARγ-campesterol interactions, with preserved protein compactness and low residue fluctuation. In vitro, UAECr and campesterol significantly enhanced glucose uptake (up to 134% vs. control, <i>p</i> < 0.001), upregulated PPARγ expression (4-fold, <i>p</i> < 0.0001), and moderately inhibited DPP-4 activity (<i>p</i> < 0.01) without cytotoxicity. <i>C. racemosa</i>-derived extracts and campesterol exert antidiabetic effects primarily via stable PPARγ-mediated insulin sensitization with complementary DPP-4 modulation, supporting its potential as a marine-derived functional food candidate.

Authors

Institutions

Publication Details

Journal
Marine Drugs
Published
2026-02-17
DOI
https://doi.org/10.3390/md24020082
Primary Topic
Seaweed-derived Bioactive Compounds
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrative Metabolomics and Systems Pharmacology Reveal PPARγ-Centered Antidiabetic Mechanisms of Caulerpa racemosa and Its Bioactive Compounds

Dante Saksono Harbuwono, Nurpudji Astuti Taslim, Fahrul Nurkolis, Happy Kurnia Permatasari et al.
Marine Drugs
Seaweed-derived Bioactive Compounds
article

Integrative Metabolomics and Systems Pharmacology Reveal PPARγ-Centered Antidiabetic Mechanisms of Caulerpa racemosa and Its Bioactive Compounds

Dante Saksono Harbuwono, Nurpudji Astuti Taslim, Fahrul Nurkolis, Happy Kurnia Permatasari, Adha Fauzi Hendrawan, Arifa Mustika, Reggie Surya, Evhy Apryani, Izza Afkarina, Annette d’Arqom, Nurmawati Fatimah, Raymond Rubianto Tjandrawinata
article en

Abstract

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder requiring safe, multitarget therapeutic strategies. Marine macroalgae represent an underexplored source of bioactives with pleiotropic metabolic effects. This study investigated the antidiabetic potential of an ultrasound-assisted ethanolic extract of <i>Caulerpa racemosa</i> (UAECr) and its key phytosterol, campesterol, through an integrative framework combining metabolomics, network pharmacology, molecular docking, molecular dynamics simulation, and in vitro validation. Untargeted ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) metabolomics characterized UAECr constituents, followed by in silico bioactivity prediction, target-network analysis, molecular docking, and 100 ns molecular dynamics simulation of the peroxisome proliferator-activated receptor gamma (PPARγ)-campesterol complex. Functional validation was performed in differentiated 3T3-L1 adipocytes assessing glucose uptake, PPARγ expression, dipeptidyl peptidase 4 (DPP-4) inhibition, and cytotoxicity. Metabolomics identified campesterol as a prominent bioactive. Network pharmacology highlighted PPARγ as a central hub, supported by strong docking affinity of campesterol toward PPARγ (-11.4 kcal/mol) and DPP-4 (-8.3 kcal/mol). Molecular dynamics simulations demonstrated stable PPARγ-campesterol interactions, with preserved protein compactness and low residue fluctuation. In vitro, UAECr and campesterol significantly enhanced glucose uptake (up to 134% vs. control, <i>p</i> < 0.001), upregulated PPARγ expression (4-fold, <i>p</i> < 0.0001), and moderately inhibited DPP-4 activity (<i>p</i> < 0.01) without cytotoxicity. <i>C. racemosa</i>-derived extracts and campesterol exert antidiabetic effects primarily via stable PPARγ-mediated insulin sensitization with complementary DPP-4 modulation, supporting its potential as a marine-derived functional food candidate.

Marine DrugsVol. 24(2)
Atma Jaya Catholic University of Indonesia (ID), Universitas Gadjah Mada (ID), Binus University (ID), University of Brawijaya (ID), Sunan Kalijaga State Islamic University Yogyakarta (ID), Universitas Airlangga (ID), Muhammadiyah University of Yogyakarta (ID), Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo (ID), Hasanuddin University (ID)
Lembaga Penelitian dan Pengabdian Kepada Masyarakat
Life below water
Openalex Percentile: Top 58%
Seaweed-derived Bioactive Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.